315 related articles for article (PubMed ID: 12390343)
1. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I; Kanaka-Gantenbein Ch; Voutetakis A; Maniati-Christidi M; Dacou-Voutetakis C
Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
[TBL] [Abstract][Full Text] [Related]
2. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
[TBL] [Abstract][Full Text] [Related]
3. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
Bonfig W; Pozza SB; Schmidt H; Pagel P; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3882-8. PubMed ID: 19622620
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ; Thomas CMG; Otten BJ; Roeleveld N; Claahsen-van der Grinten HL
J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1055-1063. PubMed ID: 31573958
[TBL] [Abstract][Full Text] [Related]
5. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z; Akbuğa S; Cetinkaya E; Ocal G; Berberoğlu M; Evliyaoğlu O; Adiyaman P
Turk J Pediatr; 2009; 51(6):539-44. PubMed ID: 20196386
[TBL] [Abstract][Full Text] [Related]
6. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Trinh L; Nimkarn S; New MI; Lin-Su K
J Pediatr Endocrinol Metab; 2007 Aug; 20(8):883-91. PubMed ID: 17937061
[TBL] [Abstract][Full Text] [Related]
7. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Bizzarri C; Improda N; Maggioli C; Capalbo D; Roma S; Porzio O; Salerno M; Cappa M
Endocr Pract; 2017 May; 23(5):546-556. PubMed ID: 28225306
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
Van der Kamp HJ; Otten BJ; Buitenweg N; De Muinck Keizer-Schrama SM; Oostdijk W; Jansen M; Delemarre-de Waal HA; Vulsma T; Wit JM
Arch Dis Child; 2002 Aug; 87(2):139-44. PubMed ID: 12138066
[TBL] [Abstract][Full Text] [Related]
9. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM; Addo OY; Kyllo J; Gonzalez-Bolanos MT; Ltief AM; Pittock S; Himes JH; Miller BS; Sarafoglou K
J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
[TBL] [Abstract][Full Text] [Related]
10. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
Hargitai G; Sólyom J; Battelino T; Lebl J; Pribilincová Z; Hauspie R; Kovács J; Waldhauser F; Frisch H;
Horm Res; 2001; 55(4):161-71. PubMed ID: 11598369
[TBL] [Abstract][Full Text] [Related]
11. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
Juan L; Huamei M; Zhe S; Yanhong L; Hongshan C; Qiuli C; Jun Z; Song G; Minlian D
J Pediatr Endocrinol Metab; 2016 Jul; 29(7):841-8. PubMed ID: 27054598
[TBL] [Abstract][Full Text] [Related]
12. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W; Schwarz HP
Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
[TBL] [Abstract][Full Text] [Related]
13. Congenital adrenal hyperplasia: lessons from a multinational study.
Frisch H; Waldhauser F; Lebl J; Solyom J; Hargitai G; Kovacs J; Pribilincova Z; Krzisnik C; Battelino T;
Horm Res; 2002; 57 Suppl 2():95-101. PubMed ID: 12065936
[TBL] [Abstract][Full Text] [Related]
14. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: final height in 27 patients with the classical form].
Lemos-Marini SH; Guerra-Júnior G; Morcillo AM; Baptista MT; Silva LO; Maciel-Guerra AT
Arq Bras Endocrinol Metabol; 2005 Dec; 49(6):902-7. PubMed ID: 16544012
[TBL] [Abstract][Full Text] [Related]
15. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
Bretones P; Riche B; Pichot E; David M; Roy P; Tardy V; Kassai B; Gaillard S; Bernoux D; Morel Y; Chatelain P; Nicolino M; Cornu C;
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1379-1388. PubMed ID: 27852974
[TBL] [Abstract][Full Text] [Related]
16. Long-term Growth in Congenital Adrenal Hyperplasia.
Maheshwari A; Khadilkar V; Gangodkar P; Khadilkar A
Indian J Pediatr; 2019 Feb; 86(2):154-158. PubMed ID: 30097840
[TBL] [Abstract][Full Text] [Related]
17. Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height.
Weintrob N; Dickerman Z; Sprecher E; Galatzer A; Pertzelan A
Eur J Endocrinol; 1997 Feb; 136(2):188-95. PubMed ID: 9116914
[TBL] [Abstract][Full Text] [Related]
18. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
Hauffa BP; Winter A; Stolecke H
Klin Padiatr; 1997; 209(2):71-7. PubMed ID: 9113619
[TBL] [Abstract][Full Text] [Related]
19. Growth and development in children with classic congenital adrenal hyperplasia.
Bonfig W
Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):39-42. PubMed ID: 27898585
[TBL] [Abstract][Full Text] [Related]
20. Final height in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the Italian experience.
Brunelli VL; Russo G; Bertelloni S; Gargantini L; Balducci R; Chiesa L; Livieri C; De Sanctis C; Einaudi S; Virdis R; Saggese G; Chiumello G
J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():277-83. PubMed ID: 12729404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
